Research graph
References from Re: Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.eururo.2026.01.008
10.1016/j.eururo.2026.01.008 · External reference
The prediction of cancer-specific mortality in T1 non-muscle-invasive bladder cancer: comparison of logistic regression and artificial neural network: a SEER population-based study
10.1007/s11255-023-03655-5 · 2023 · External reference
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study
10.1111/bju.16780 · 2025 · External reference
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance
10.1016/j.eururo.2012.10.039 · 2013 · External reference
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials
10.1016/s0022-5347(05)64273-5 · 2002 · External reference
